Trial Profile
A randomized, double-blind, placebo-controlled, parallel group study to evaluate the efficacy and safety of dupilumab in adolescents and adults with moderate to severe uncontrolled asthma
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 17 Jun 2016
Price :
$35
*
At a glance
- Drugs Dupilumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- Acronyms RESP 3821
- 26 Oct 2015 New trial record